Magtrax 250mg Injection
Marketer
Magnus Biotech Pvt Ltd
Salt Composition
Ceftriaxone (250mg)
Overview Magtrax 250mg Injection
Cefixime 250mg Injection, a cephalosporin antibiotic, combats various bacterial infections. Its applications span diverse sites including the brain (meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, blood, and heart. Prophylactically, it's used pre-surgery to prevent infection. Administered intravenously or intramuscularly by a healthcare professional, dosage is determined individually. Consistent, evenly spaced dosing as directed is crucial; premature cessation risks relapse. Common side effects, usually mild, encompass diarrhea, rash, altered liver function tests, and variations in blood cell counts (eosinophilia, leukopenia, thrombocytopenia). Injection site reactions (erythema, pain) may occur. Inform your doctor of any antibiotic allergies, kidney or liver issues, or other medications you're using, as interactions are possible.
Uses of Magtrax 250mg Injection
Combating Bacterial Infections
Major Benefits of Magtrax 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Magtrax 250mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Magtrax 250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Magtrax 250mg Injection works:
The antibiotic injection, Magtrax 250mg, works by disrupting bacterial cell wall synthesis, thereby eliminating the bacteria's protective barrier and causing their demise.
SAFETY ADVICE
AlcoholSAFE
The concomitant use of alcohol and Magtrax 250mg Injection is not associated with adverse reactions.
PregnancySAFE IF PRESCRIBED
Administering Magtrax 250mg Injection during pregnancy is considered safe. The preponderance of research indicates minimal to nonexistent risk to the fetus.
Breast feedingCAUTION
Administering Magtrax 250mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Magtrax 250mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if any of these effects manifest.
KidneySAFE IF PRESCRIBED
Magtrax 250mg Injection can be administered to patients with kidney impairment without altering the dosage. Nevertheless, disclosure of pre-existing renal conditions to your physician is advised.
LiverCAUTION
Administering Magtrax 250mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage changes for Magtrax 250mg Injection are unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Magtrax 250mg Injection :
Forgetting a dose of Magtrax 250mg Injection? Seek medical advice.
Facts to Know About Magtrax 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently